Evidence map›Paper›PMID 32366677›Full record

ArticleDevelopment (Cambridge, England)2020

A collection of genetic mouse lines and related tools for inducible and reversible intersectional mis-expression.

Elham Ahmadzadeh, N Sumru Bayin, Xinli Qu, Aditi Singh, Linda Madisen, Daniel Stephen, Hongkui Zeng, Alexandra L Joyner, Alberto Rosello-Diez

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Dysregulated miR-124-3p in endometrial epithelial cells reduces endometrial receptivity by altering polarity and adhesion.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elham AhmadzadehAustralian Regenerative Medicine Institute, Monash University, Clayton, VIC 3800. Australia.
N Sumru BayinDevelopmental Biology Program, Sloan Kettering Institute, New York, NY 10065, USA.
Xinli QuAustralian Regenerative Medicine Institute, Monash University, Clayton, VIC 3800. Australia.
Aditi SinghAustralian Regenerative Medicine Institute, Monash University, Clayton, VIC 3800. Australia.
Linda MadisenAllen Institute for Brain Science, Seattle, WA 98109, USA.
Daniel StephenDevelopmental Biology Program, Sloan Kettering Institute, New York, NY 10065, USA.
Hongkui ZengAllen Institute for Brain Science, Seattle, WA 98109, USA.
Alexandra L JoynerDevelopmental Biology Program, Sloan Kettering Institute, New York, NY 10065, USA alberto.rosellodiez@monash.edu joynera@mskcc.org.ORCID 0000-0001-7090-9605
Alberto Rosello-DiezAustralian Regenerative Medicine Institute, Monash University, Clayton, VIC 3800. Australia alberto.rosellodiez@monash.edu joynera@mskcc.org.ORCID 0000-0002-5550-9846

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Generation of novel cell type specific mouse genetic toolsU19MH114830 · NIMH · ALLEN INSTITUTE · PI PACHTER, LIOR S · 2017 to 2021
$64.7M
Engrailed genes and cerebellum morphology, spatial gene expression and circuitryR37MH085726 · NIMH · SLOAN-KETTERING INST CAN RESEARCH · PI JOYNER, ALEXANDRA L. · 2014 to 2023
$6.7M
Signaling Pathways that Regulate Scaling and Regeneration of the CerebellumR01NS092096 · NINDS · SLOAN-KETTERING INST CAN RESEARCH · PI JOYNER, ALEXANDRA L. · 2015 to 2024
$4.8M
A transgenic platform to produce genetic tools for monitoring & manipulating plasR01DA028298 · NIDA · ALLEN INSTITUTE · PI ZENG, HONGKUI · 2009 to 2013
$2.2M
Generation and characterization of novel and highly specific neruonal subtype traR01MH085500 · NIMH · ALLEN INSTITUTE · PI NAGY, ANDRAS, ZENG, HONGKUI · 2008 to 2011
$1.2M
A novel genetic approach to perturb and study coordination of organ growthR21HD083860 · NICHD · SLOAN-KETTERING INST CAN RESEARCH · PI JOYNER, ALEXANDRA L. · 2015 to 2016
$492k
Unraveling stem cell behaviors upon injury to the brainK99NS112605 · NINDS · SLOAN-KETTERING INST CAN RESEARCH · PI BAYIN, NERMIN SUMRU · 2019 to 2020
$188k
NCI NIH HHS P30 CA008748NICHD NIH HHS R21 HD083860NIDA NIH HHS R01 DA028298NIMH NIH HHS R37 MH085726NIMH NIH HHS U19 MH114830NINDS NIH HHS K99 NS112605NINDS NIH HHS R01 NS092096
6 · The paper itself

Abstract

Thanks to many advances in genetic manipulation, mouse models have become very powerful in their ability to interrogate biological processes. In order to precisely target expression of a gene of interest to particular cell types, intersectional genetic approaches using two promoter/enhancers unique to a cell type are ideal. Within these methodologies, variants that add temporal control of gene expression are the most powerful. We describe the development, validation and application of an intersectional approach that involves three transgenes, requiring the intersection of two promoter/enhancers to target gene expression to precise cell types. Furthermore, the approach uses available lines expressing tTA/rTA to control the timing of gene expression based on whether doxycycline is absent or present, respectively. We also show that the approach can be extended to other animal models, using chicken embryos. We generated three mouse lines targeted at the

Indexed as

Disease Models, AnimalGene Transfer TechniquesTransgenesAnimalsCerebellumChick EmbryoDoxycyclineExtremitiesFemaleGene ExpressionGene Expression RegulationMaleMiceMice, TransgenicPromoter Regions, GeneticTrans-ActivatorsDoxycyclineTrans-ActivatorsCcn2/CtgfCreDiphtheria toxinDRAGONDTAInducible and reversible gene mis-expressionIntersectional geneticsp21rtTATigre locusTissue-specifictox176tTA

Identifiers

PMID32366677
PMCPMC7272339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.